YOUL:NASDAQYoulife Group Inc. Analysis
Data as of 2026-05-12 - not real-time
$0.94
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Youlife Group Inc. (YOUL) is trading at $0.94, comfortably above its computed support of $0.78 but well below the 200‑day SMA of $1.50, indicating a long‑term downtrend. The 20‑day SMA (0.97) sits beneath the 50‑day SMA (1.00), reinforcing a bearish short‑term bias. Momentum is mixed, with an RSI of 48 suggesting neither overbought nor oversold conditions and a MACD that has just crossed into bullish territory but remains near zero. Volume is on a decreasing trend, and the 30‑day volatility is extremely high at roughly 81%, pointing to erratic price swings. Fundamentally, the company posted a 17.7% revenue increase year‑over‑year, yet operating margins are negative and profit margins are thin at just over 2%. The P/E ratio of 10.4 looks cheap, but the negative book value (PB –0.74) and a maximal historical drawdown of 83% underscore underlying fragility.
The balance sheet shows modest cash ($144 M) against a comparable debt load ($158 M), yielding a debt‑to‑equity ratio above 20, which limits financial flexibility. A beta of 0.26 indicates low market correlation, but the stock’s idiosyncratic risk is high given its sector (Consumer Defensive – Education & Training) in China, where regulatory scrutiny is intense. Liquidity is a concern: average daily volume hovers around 27 K shares for a market cap under $72 M, and the trend is downward. No dividend is paid, eliminating any income cushion for investors. The Fear & Greed Index sits at “Extreme Greed,” suggesting market optimism that may be disconnected from the company’s fundamentals. Overall, the blend of cheap valuation, modest growth, and pronounced risk factors leads to a cautious outlook.
The balance sheet shows modest cash ($144 M) against a comparable debt load ($158 M), yielding a debt‑to‑equity ratio above 20, which limits financial flexibility. A beta of 0.26 indicates low market correlation, but the stock’s idiosyncratic risk is high given its sector (Consumer Defensive – Education & Training) in China, where regulatory scrutiny is intense. Liquidity is a concern: average daily volume hovers around 27 K shares for a market cap under $72 M, and the trend is downward. No dividend is paid, eliminating any income cushion for investors. The Fear & Greed Index sits at “Extreme Greed,” suggesting market optimism that may be disconnected from the company’s fundamentals. Overall, the blend of cheap valuation, modest growth, and pronounced risk factors leads to a cautious outlook.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- price near support level with limited upside
- bearish trend and decreasing volume
- high short‑term volatility
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- revenue growth of ~18% suggests upside potential
- valuation appears cheap relative to earnings
- ongoing regulatory uncertainty in Chinese education
Long Term
> 3 yearsPositive
Model confidence: 6/10
Key Factors
- potential market share in blue‑collar services
- undervalued price relative to earnings
- long‑run demographic demand for vocational training
Key Metrics & Analysis
Financial Health
Revenue Growth17.70%
Profit Margin2.32%
P/E Ratio10.4
ROE6.36%
ROA0.39%
Debt/Equity21.02
P/B Ratio-0.7
Technical Analysis
TrendBearish
RSI47.6
Support$0.78
Resistance$1.13
MA 20$0.97
MA 50$1.00
MA 200$1.50
MACDBullish
VolumeDecreasing
Fear & Greed Index88.61
Valuation
GradeUndervalued
TypeBlend
Risk Assessment
Beta0.26
Volatility80.92%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh
Similar Tickers
ZKH
ZKH Group Limited
STOCKZJYL
JIN MEDICAL INTERNATIONAL LTD.
STOCKZJK
ZJK Industrial Co., Ltd.
STOCKZIP
ZipRecruiter, Inc.
STOCKZIONP
Zions Bancorporation N.A. - Depositary Shares each representing a 1/40th ownership interest in a share of Series A Floating-Rate Non-Cumulative Perpetual Prefer
STOCKZION
Zions Bancorporation N.A.
STOCKThis analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.